ATE266024T1 - Indolderivate die zur behandlung von störungen des cns benutzt werden können - Google Patents

Indolderivate die zur behandlung von störungen des cns benutzt werden können

Info

Publication number
ATE266024T1
ATE266024T1 AT01960182T AT01960182T ATE266024T1 AT E266024 T1 ATE266024 T1 AT E266024T1 AT 01960182 T AT01960182 T AT 01960182T AT 01960182 T AT01960182 T AT 01960182T AT E266024 T1 ATE266024 T1 AT E266024T1
Authority
AT
Austria
Prior art keywords
cns
indole derivatives
treat disorders
disorders
treat
Prior art date
Application number
AT01960182T
Other languages
English (en)
Inventor
Jakob Felding
Benny Bang-Andersen
Garrick Paul Smith
Kim Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Application granted granted Critical
Publication of ATE266024T1 publication Critical patent/ATE266024T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT01960182T 2000-07-21 2001-07-17 Indolderivate die zur behandlung von störungen des cns benutzt werden können ATE266024T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001123 2000-07-21
PCT/DK2001/000507 WO2002008223A1 (en) 2000-07-21 2001-07-17 Indole derivatives useful for the treatment of cns disorders

Publications (1)

Publication Number Publication Date
ATE266024T1 true ATE266024T1 (de) 2004-05-15

Family

ID=8159625

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01960182T ATE266024T1 (de) 2000-07-21 2001-07-17 Indolderivate die zur behandlung von störungen des cns benutzt werden können

Country Status (28)

Country Link
US (1) US6743809B2 (de)
EP (1) EP1305307B1 (de)
JP (1) JP2004504396A (de)
KR (1) KR100851793B1 (de)
CN (1) CN1264838C (de)
AR (1) AR029858A1 (de)
AT (1) ATE266024T1 (de)
AU (2) AU8173801A (de)
BG (1) BG107528A (de)
BR (1) BR0112998A (de)
CA (1) CA2416212C (de)
CZ (1) CZ301114B6 (de)
DE (1) DE60103162T2 (de)
EA (1) EA004749B1 (de)
ES (1) ES2219554T3 (de)
HR (1) HRP20030015A2 (de)
HU (1) HUP0302820A3 (de)
IL (2) IL153605A0 (de)
IS (1) IS2172B (de)
MX (1) MXPA02012927A (de)
NO (1) NO323799B1 (de)
NZ (1) NZ523436A (de)
PT (1) PT1305307E (de)
SK (1) SK286701B6 (de)
TR (1) TR200401488T4 (de)
UA (1) UA73995C2 (de)
WO (1) WO2002008223A1 (de)
ZA (1) ZA200300287B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2382037C2 (ru) 2003-11-17 2010-02-20 Бёрингер Ингельхайм Интернациональ Гмбх Новые пиперидинзамещенные индолы или их гетеропроизводные
TWI391387B (zh) * 2004-05-12 2013-04-01 Eisai R&D Man Co Ltd 具有哌啶環之吲哚衍生物
ATE531706T1 (de) 2005-04-30 2011-11-15 Boehringer Ingelheim Int Neue piperidin-substituierte indole und ihre verwendung als ccr-3-modulatoren
EP2079725B1 (de) 2006-10-27 2011-12-14 Boehringer Ingelheim International GmbH Piperidylpropanthiole als ccr3-modulatoren
CN101486654B (zh) * 2009-03-04 2012-10-10 西安近代化学研究所 2-甲基-3-硝基苯乙酸合成方法
CN110041318B (zh) * 2018-01-17 2022-07-29 中国科学院上海药物研究所 一类多巴胺d5受体激动剂及其制备和应用
CN110498789B (zh) * 2018-05-17 2022-04-05 上海医药工业研究院 芳烷哌啶类衍生物及其在多靶点抗抑郁症中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322470A1 (de) * 1973-05-04 1974-11-21 Boehringer Sohn Ingelheim Neue indolyl-piperidino-(bzw. 1,2,5,6tetrahydro-pyridyl-)butyrophenone und verfahren zu ihrer herstellung
AT332401B (de) * 1973-11-26 1976-09-27 Roussel Uclaf Verfahren zur herstellung von neuen (4'-(3''-indolyl)-piperidino)-alkylarylketonderivaten
AU611469B2 (en) * 1987-08-13 1991-06-13 Glaxo Group Limited Indole derivatives
GB8719167D0 (en) 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
FI950486A0 (fi) * 1992-08-05 1995-02-03 Wyeth John & Brother Ltd Amidijohdannaiset
KR960701865A (ko) * 1993-04-22 1996-03-28 데이비드 존. 우드 편두통에 사용하는 5-HT1 유사 효능제인 인돌 유도체(Indole Derivatives as 5-HT, -Like Agonists for Use in Migraine)
ES2063700B1 (es) * 1993-04-28 1995-07-16 Vita Invest Sa Agente activo sobre el sistema nervioso central, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
US5576321A (en) * 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
GB9718712D0 (en) * 1997-09-03 1997-11-12 Merck Sharp & Dohme Theraputic Agents

Also Published As

Publication number Publication date
EA200300179A1 (ru) 2003-06-26
CZ301114B6 (cs) 2009-11-11
IS2172B (is) 2006-11-15
BG107528A (bg) 2003-10-31
EP1305307A1 (de) 2003-05-02
SK2032003A3 (en) 2003-06-03
HUP0302820A3 (en) 2006-04-28
EP1305307B1 (de) 2004-05-06
IS6663A (is) 2002-12-23
JP2004504396A (ja) 2004-02-12
NZ523436A (en) 2004-07-30
WO2002008223A1 (en) 2002-01-31
PL359157A1 (en) 2004-08-23
EA004749B1 (ru) 2004-08-26
TR200401488T4 (tr) 2004-08-23
NO323799B1 (no) 2007-07-09
SK286701B6 (sk) 2009-03-05
NO20030127L (no) 2003-01-10
KR100851793B1 (ko) 2008-08-13
IL153605A (en) 2008-07-08
ZA200300287B (en) 2004-03-02
AR029858A1 (es) 2003-07-16
PT1305307E (pt) 2004-09-30
ES2219554T3 (es) 2004-12-01
UA73995C2 (en) 2005-10-17
AU8173801A (en) 2002-02-05
US6743809B2 (en) 2004-06-01
DE60103162D1 (de) 2004-06-09
HRP20030015A2 (en) 2005-02-28
BR0112998A (pt) 2003-06-24
KR20030017643A (ko) 2003-03-03
DE60103162T2 (de) 2005-05-04
MXPA02012927A (es) 2003-05-15
CN1451002A (zh) 2003-10-22
NO20030127D0 (no) 2003-01-10
CN1264838C (zh) 2006-07-19
CA2416212A1 (en) 2002-01-31
US20030166664A1 (en) 2003-09-04
HK1059782A1 (en) 2004-07-16
IL153605A0 (en) 2003-07-06
CZ2003196A3 (cs) 2003-05-14
HUP0302820A2 (hu) 2003-12-29
CA2416212C (en) 2007-10-30
AU2001281738B2 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
ATE247117T1 (de) Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen
ATE305307T1 (de) Reboxetin zur behandlung von migränekopfschmerzen
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60118205D1 (de) 4-, 5-, 6- und 7-indolderivate die in der behandlung von störungen des cns benutzt werden können
ATE266024T1 (de) Indolderivate die zur behandlung von störungen des cns benutzt werden können
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60111379D1 (de) Indolderivate zum gebrauch in der behandlung von zns-störungen
EA200401423A1 (ru) Пиперазинбензотиазолы, используемые в качестве средств для лечения церебральных ишемических расстройств или расстройств цнс
DE60036723D1 (de) Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen
DE60110897D1 (de) Der duale inhibitor der cholesterylester und wachsester synthese avasimibe zur behandlung von erkrankungen des talgdrüse
ATE268765T1 (de) Indolderivate zum gebrauch in der behandlung von zns-störungen
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen
ATE262525T1 (de) Indolderivate zur verwendung in der behandlung von zns-störungen
ATE345818T1 (de) S-methyl-dihydro-ziprasidone zur behandlung von psychiatrischen störungen.
NO20024331D0 (no) Behandling av lidelser relatert til det serotonerge system
ATA19702000A (de) Einrichtung zur physikalischen behandlung von trinkwasser
NO20050146D0 (no) N,N-disubstituerte diazocykloalkaner nyttige i behandling av CNS-forstyrrelser grunnet serotonergisk dysfunksjon
ATE369354T1 (de) Isochinolin-aroylpyrrole für die behandlung von krankheiten des zentralnervensystems
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
IL153234A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1305307

Country of ref document: EP

REN Ceased due to non-payment of the annual fee